These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15623758)

  • 41. Strategies for control of trachoma: observational study with quantitative PCR.
    Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
    Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diversity of Chlamydia trachomatis in Trachoma-Hyperendemic Communities Treated With Azithromycin.
    Chin SA; Morberg DP; Alemayehu W; Melese M; Lakew T; Chen MC; Zhou Z; Doan T; Cevallos V; Lietman TM; Keenan JD
    Am J Epidemiol; 2018 Sep; 187(9):1840-1845. PubMed ID: 29617922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
    JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
    Campbell JP; Mkocha H; Munoz B; West SK
    Ophthalmic Epidemiol; 2012 Feb; 19(1):38-42. PubMed ID: 22273357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?
    Thein J; Zhao P; Liu H; Xu J; Jha H; Miao Y; Pizzarello L; Tapert L; Schachter J; Mabon M; Osaki-Holm S; Lietman T; Paxton A
    Ophthalmic Epidemiol; 2002 Oct; 9(4):263-9. PubMed ID: 12187424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
    Gambhir M; Basáñez MG; Burton MJ; Solomon AW; Bailey RL; Holland MJ; Blake IM; Donnelly CA; Jabr I; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e462. PubMed ID: 19529762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.
    Goodhew EB; Morgan SM; Switzer AJ; Munoz B; Dize L; Gaydos C; Mkocha H; West SK; Wiegand RE; Lammie PJ; Martin DL
    BMC Infect Dis; 2014 Apr; 14():216. PubMed ID: 24755001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chlamydia on children and flies after mass antibiotic treatment for trachoma.
    Lee S; Alemayehu W; Melese M; Lakew T; Lee D; Yi E; Cevallos V; Donnellan C; Zhou Z; Chidambaram JD; Gaynor BD; Whitcher JP; Lietman TM
    Am J Trop Med Hyg; 2007 Jan; 76(1):129-31. PubMed ID: 17255240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of molecular tools in the control of blinding trachoma.
    Mabey D; Solomon AW
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):11-7. PubMed ID: 14692675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; Zhou Z; Bailey RL; Mabey DC; Porco TC; Keenan JD; Gaynor BD; West SK; Lietman TM
    Clin Infect Dis; 2017 Mar; 64(6):743-750. PubMed ID: 27956455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
    Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of community level treatment and preventative interventions on trachoma prevalence in rural Ethiopia.
    Cumberland P; Edwards T; Hailu G; Harding-Esch E; Andreasen A; Mabey D; Todd J
    Int J Epidemiol; 2008 Jun; 37(3):549-58. PubMed ID: 18356196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.
    Yang JL; Schachter J; Moncada J; Habte D; Zerihun M; House JI; Zhou Z; Hong KC; Maxey K; Gaynor BD; Lietman TM
    Br J Ophthalmol; 2007 Mar; 91(3):293-5. PubMed ID: 17050583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop?
    Burton MJ; Holland MJ; Jeffries D; Mabey DC; Bailey RL
    Clin Infect Dis; 2006 Feb; 42(4):463-70. PubMed ID: 16421789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.